APGE Q1 2026 Earnings Apogee Therapeutics Narrows Loss Per Share Stock Slips Slightly NVS Q1 2026 Earnings EPS Misses Estimates by 85 Stock Declines Slightly Kiniksa Pharmaceuticals Q1 2026 Earnings EPS Surprises by 315 Despite Stock Decline GLUE Q1 2026 Earnings WiderThanExpected Loss as PreClinical Biotech Advances Pipeline CTO Q1 2026 Earnings Massive EPS Beat as Earnings Surge Past Estimates CVNA Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Uncertainty